Dmitry Garmaev, | |
2500 Farmington Ave, Farmington, NM 87401-4504 | |
(505) 609-6830 | |
Not Available |
Full Name | Dmitry Garmaev |
---|---|
Gender | Male |
Speciality | Pain Management |
Experience | 27 Years |
Location | 2500 Farmington Ave, Farmington, New Mexico |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720321532 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | MD2018-0224 (New Mexico) | Secondary |
207LP2900X | Anesthesiology - Pain Medicine | MD2018-0224 (New Mexico) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
San Juan Regional Medical Center | Farmington, NM | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
San Juan Regional Medical Center, Inc. | 4587559505 | 177 |
News Archive
Silence may be more golden for women, suggests a new study at Green Mountain College in Poultney, Vermont, which found that couples were judged to be less likeable when the woman was more verbally assertive.
A Washington State University researcher says attractive businesswomen are considered less trustworthy, less truthful and more worthy of being fired than less attractive women.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA).
Medical device pioneer Stentys announced today that the first patient has been enrolled into the ‘APPOSITION II' clinical study—a randomized trial comparing the Stentys self-expanding stent with a conventional balloon-expandable stent in AMI patients. The primary endpoint of the ‘APPOSITION II' study is stent strut apposition at day three post-procedure via extremely high-resolution OCT (optical coherence tomography) imaging.
› Verified 2 days ago
Entity Name | San Juan Regional Medical Center, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1639662901 PECOS PAC ID: 4587559505 Enrollment ID: O20040218000865 |
News Archive
Silence may be more golden for women, suggests a new study at Green Mountain College in Poultney, Vermont, which found that couples were judged to be less likeable when the woman was more verbally assertive.
A Washington State University researcher says attractive businesswomen are considered less trustworthy, less truthful and more worthy of being fired than less attractive women.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA).
Medical device pioneer Stentys announced today that the first patient has been enrolled into the ‘APPOSITION II' clinical study—a randomized trial comparing the Stentys self-expanding stent with a conventional balloon-expandable stent in AMI patients. The primary endpoint of the ‘APPOSITION II' study is stent strut apposition at day three post-procedure via extremely high-resolution OCT (optical coherence tomography) imaging.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dmitry Garmaev, Po Box 6210, Farmington, NM 87499-6210 Ph: (505) 609-2258 | Dmitry Garmaev, 2500 Farmington Ave, Farmington, NM 87401-4504 Ph: (505) 609-6830 |
News Archive
Silence may be more golden for women, suggests a new study at Green Mountain College in Poultney, Vermont, which found that couples were judged to be less likeable when the woman was more verbally assertive.
A Washington State University researcher says attractive businesswomen are considered less trustworthy, less truthful and more worthy of being fired than less attractive women.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA).
Medical device pioneer Stentys announced today that the first patient has been enrolled into the ‘APPOSITION II' clinical study—a randomized trial comparing the Stentys self-expanding stent with a conventional balloon-expandable stent in AMI patients. The primary endpoint of the ‘APPOSITION II' study is stent strut apposition at day three post-procedure via extremely high-resolution OCT (optical coherence tomography) imaging.
› Verified 2 days ago
Michael Ray Vandusen, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 801 W Maple St, Farmington, NM 87401 Phone: 505-609-2000 Fax: 505-609-2259 | |
Dr. David P Goldstein, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2300 E 30th St Bldg A, Farmington, NM 87401 Phone: 505-326-6400 Fax: 505-326-4606 | |
Jan A Gotta, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 801 W Maple St, Farmington, NM 87401 Phone: 505-326-6400 Fax: 505-326-4606 | |
Samuel Eric Aikele, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 801 W Maple St, Farmington, NM 87401 Phone: 505-609-2000 | |
Maria Celina Jensen, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1515 E 20th St, Suite A, Farmington, NM 87401 Phone: 505-326-6400 | |
Dr. Joseph Leland Davidson, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 801 W Maple St, Farmington, NM 87401 Phone: 505-609-2000 | |
Charles E Bruerd, D.O. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 801 W Maple St, Farmington, NM 87401 Phone: 505-326-6400 Fax: 505-326-4606 |